Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CXCL10 |
| Upstream (Parents) |
|---|
| (<<) CXCL11 → CXCL10 |
| (<<) CXCL9 → CXCL10 |
| (<<) GBP1 → CXCL10 |
| (<<) TFEC → CXCL10 |
| (<<) TRBC1 → CXCL10 |
| (<<) IDO1 → CXCL10 |
| Downstream (Children) |
|---|
| CXCL10 → EAF2 (>>) |
| CXCL10 → UBD///GABBR1 (>>) |
| CXCL10 → CXCL11 (>>) |
| CXCL10 → KYNU (>>) |
| CXCL10 → CXCL9 (>>) |
| CXCL10 → IFI44L (>>) |
| CXCL10 → RTP4 (>>) |
| CXCL10 → TARP///TRGC2 (>>) |
| CXCL10 → GNLY (>>) |
| CXCL10 → ADAMDEC1 (>>) |
| CXCL10 → RSAD2 (>>) |
| CXCL10 → LAG3 (>>) |
| CXCL10 → C17orf60 (>>) |
| CXCL10 → HCP5 (>>) |
| CXCL10 → SLAMF8 (>>) |
| CXCL10 → BCL2A1 (>>) |
| CXCL10 → GBP1 (>>) |
| CXCL10 → TFEC (>>) |
| CXCL10 → ZNF214 (>>) |
| CXCL10 → PSMB9 (>>) |
| CXCL10 → TAP1 (>>) |
| CXCL10 → IFI44 (>>) |
| CXCL10 → SAMD9 (>>) |
| CXCL10 → IDO1 (>>) |
| CXCL10 → IL21R (>>) |
